Corvus hawaiiensis isolate bCorHaw1 chromosome 29, bCorHaw1.pri.cur, whole genome shotgun sequence.
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Archelosauria; Archosauria; Dinosauria; Saurischia; Theropoda; Coelurosauria; Aves; Neognathae; Passeriformes; Corvoidea; Corvidae; Corvus.
REFSEQ INFORMATION: The reference sequence is identical to\nCM036374.1.\nAssembly name: bCorHaw1.pri.cur\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Vertebrate Genomes Project on\n2021/11/04. The original whole-genome shotgun project has the\naccession JAJGSY000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Vertebrate Genomes Project\nAssembly Date :: 20-SEP-2021\nAssembly Method :: HiFiasm v. 0.15.4+galaxy; purge_dups v.\n 1.2.5+galaxy3; Bionano Solve v.\n 3.6.1+galaxy2; Salsa v. 2.3+galaxy0;\n gEVAL manual curation v. 2021-09-20; VGP\n pipeline v. 2.0\nAssembly Name :: bCorHaw1.pri.cur\nDiploid :: Principal Pseudohaplotype\nGenome Representation :: Full\nExpected Final Version :: No\nGenome Coverage :: 29.61x\nSequencing Technology :: PacBio Sequel II HiFi; Illumina NovaSeq;\n Bionano Genomics Saphyr DLS; Arima\n Genomics Hi-C v2\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Corvus hawaiiensis Annotation\n Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC125318376, transcript variant X2
uncharacterized LOC125318376, transcript variant X1
uncharacterized LOC125318415, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC125318415, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized LOC125318415, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 42 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 97% coverage of the annotated genomic feature by RNAseq alignments
translocon-associated protein subunit beta, transcript variant X1
COORDINATES: polyA evidence [ECO:0006239]
translocon-associated protein subunit beta, transcript variant X2
translocon-associated protein subunit beta
zinc finger and BTB domain containing 7B, transcript variant X3
zinc finger and BTB domain containing 7B, transcript variant X2
zinc finger and BTB domain containing 7B, transcript variant X6
zinc finger and BTB domain containing 7B, transcript variant X5
zinc finger and BTB domain containing 7B, transcript variant X4
zinc finger and BTB domain containing 7B, transcript variant X1
zinc finger and BTB domain-containing protein 7B isoform X1
zinc finger and BTB domain-containing protein 7B isoform X2
mothers against decapentaplegic homolog 6-like, transcript variant X2
mothers against decapentaplegic homolog 6-like, transcript variant X1
mothers against decapentaplegic homolog 6-like isoform X2
mothers against decapentaplegic homolog 6-like isoform X1
flavin adenine dinucleotide synthetase 1, transcript variant X4
flavin adenine dinucleotide synthetase 1, transcript variant X3
flavin adenine dinucleotide synthetase 1, transcript variant X2
flavin adenine dinucleotide synthetase 1, transcript variant X1
CDC28 protein kinase regulatory subunit 1B, transcript variant X1
CDC28 protein kinase regulatory subunit 1B, transcript variant X2
cyclin-dependent kinases regulatory subunit 1 isoform X1
cyclin-dependent kinases regulatory subunit 1 isoform X2
SHC adaptor protein 1, transcript variant X6
SHC adaptor protein 1, transcript variant X5
SHC adaptor protein 1, transcript variant X7
SHC adaptor protein 1, transcript variant X8
SHC adaptor protein 1, transcript variant X3
SHC adaptor protein 1, transcript variant X4
SHC adaptor protein 1, transcript variant X1
SHC adaptor protein 1, transcript variant X2
pygopus family PHD finger 2, transcript variant X1
pygopus family PHD finger 2, transcript variant X2
pre-B-cell leukemia transcription factor-interacting protein 1
phosphomevalonate kinase, transcript variant X1
phosphomevalonate kinase, transcript variant X2
potassium calcium-activated channel subfamily N member 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
small conductance calcium-activated potassium channel protein 3
adenosine deaminase RNA specific, transcript variant X2
adenosine deaminase RNA specific, transcript variant X1
double-stranded RNA-specific adenosine deaminase
cholinergic receptor nicotinic beta 2 subunit
neuronal acetylcholine receptor subunit beta-2
interleukin 6 receptor, transcript variant X2
interleukin 6 receptor, transcript variant X1
interleukin-6 receptor subunit alpha isoform X2
interleukin-6 receptor subunit alpha isoform X1
ATPase phospholipid transporting 8B2, transcript variant X3
ATPase phospholipid transporting 8B2, transcript variant X2
ATPase phospholipid transporting 8B2, transcript variant X4
ATPase phospholipid transporting 8B2, transcript variant X1
ATPase phospholipid transporting 8B2, transcript variant X5
phospholipid-transporting ATPase ID isoform X3
phospholipid-transporting ATPase ID isoform X2
phospholipid-transporting ATPase ID isoform X4
phospholipid-transporting ATPase ID isoform X1
phospholipid-transporting ATPase ID isoform X5
ubiquitin associated protein 2 like, transcript variant X1
ubiquitin associated protein 2 like, transcript variant X2
ubiquitin associated protein 2 like, transcript variant X3
ubiquitin associated protein 2 like, transcript variant X4
ubiquitin associated protein 2 like, transcript variant X11
ubiquitin associated protein 2 like, transcript variant X6
ubiquitin associated protein 2 like, transcript variant X5
ubiquitin associated protein 2 like, transcript variant X9
ubiquitin associated protein 2 like, transcript variant X7
ubiquitin associated protein 2 like, transcript variant X13
ubiquitin associated protein 2 like, transcript variant X10
ubiquitin associated protein 2 like, transcript variant X8
ubiquitin associated protein 2 like, transcript variant X12
ubiquitin-associated protein 2-like isoform X12
ubiquitin-associated protein 2-like isoform X10
ubiquitin-associated protein 2-like isoform X9
ubiquitin-associated protein 2-like isoform X5
ubiquitin-associated protein 2-like isoform X7
ubiquitin-associated protein 2-like isoform X4
ubiquitin-associated protein 2-like isoform X11
ubiquitin-associated protein 2-like isoform X8
ubiquitin-associated protein 2-like isoform X2
ubiquitin-associated protein 2-like isoform X6
ubiquitin-associated protein 2-like isoform X3
ubiquitin-associated protein 2-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 54 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 68 samples with support for all annotated introns
uncharacterized LOC125318422, transcript variant X2
uncharacterized protein LOC125318422 isoform X2
uncharacterized LOC125318422, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
uncharacterized protein LOC125318422 isoform X1
transmembrane protein 79, transcript variant X1
transmembrane protein 79, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
SMG5 nonsense mediated mRNA decay factor
nonsense-mediated mRNA decay factor SMG5
bone gamma-carboxyglutamate protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
bone gamma-carboxyglutamate protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
solute carrier family 25 member 44, transcript variant X1
solute carrier family 25 member 44, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments, including 53 samples with support for all annotated introns
late endosomal/lysosomal adaptor, MAPK and MTOR activator 2
tetratricopeptide repeat domain 24, transcript variant X3
tetratricopeptide repeat protein 24 isoform X3
tetratricopeptide repeat domain 24, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
tetratricopeptide repeat domain 24, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
tetratricopeptide repeat protein 24 isoform X1
tetratricopeptide repeat protein 24 isoform X2
IQ motif containing GTPase activating protein 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
ras GTPase-activating-like protein IQGAP3
myocyte enhancer factor 2D, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
myocyte enhancer factor 2D, transcript variant X6
myocyte enhancer factor 2D, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 57 samples with support for all annotated introns
myocyte enhancer factor 2D, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 62 samples with support for all annotated introns
myocyte enhancer factor 2D, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 55 samples with support for all annotated introns
myocyte enhancer factor 2D, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 49 samples with support for all annotated introns
myocyte enhancer factor 2D, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 51 samples with support for all annotated introns
myocyte enhancer factor 2D, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
myocyte enhancer factor 2D, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
myocyte-specific enhancer factor 2D isoform X1
myocyte-specific enhancer factor 2D isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: ammonium transporter Rh type B
hyaluronan and proteoglycan link protein 2
basic salivary proline-rich protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
cellular retinoic acid binding protein 2
cellular retinoic acid-binding protein 2
interferon stimulated exonuclease gene 20 like 2
interferon-stimulated 20 kDa exonuclease-like 2
methyltransferase like 25B, transcript variant X2
methyltransferase-like protein 25B isoform X2
methyltransferase like 25B, transcript variant X1
methyltransferase-like protein 25B isoform X1
mitochondrial ribosomal protein L24, transcript variant X2
mitochondrial ribosomal protein L24, transcript variant X1
39S ribosomal protein L24, mitochondrial
proline rich mitotic checkpoint control factor
SH2 domain containing 2A, transcript variant X2
SH2 domain containing 2A, transcript variant X1
SH2 domain-containing protein 2A isoform X1
SH2 domain-containing protein 2A isoform X2
death-associated protein kinase 2-like, transcript variant X1
death-associated protein kinase 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
high affinity nerve growth factor receptor
platelet endothelial aggregation receptor 1
ADAM metallopeptidase domain 15, transcript variant X1
ADAM metallopeptidase domain 15, transcript variant X4
ADAM metallopeptidase domain 15, transcript variant X3
ADAM metallopeptidase domain 15, transcript variant X5
ADAM metallopeptidase domain 15, transcript variant X2
disintegrin and metalloproteinase domain-containing protein 15 isoform X1
disintegrin and metalloproteinase domain-containing protein 15 isoform X4
disintegrin and metalloproteinase domain-containing protein 15 isoform X3
disintegrin and metalloproteinase domain-containing protein 15 isoform X5
disintegrin and metalloproteinase domain-containing protein 15 isoform X2
dolichyl-phosphate mannosyltransferase subunit 3, regulatory
dolichol-phosphate mannosyltransferase subunit 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: lysosomal acid glucosylceramidase-like
lysosomal acid glucosylceramidase-like, transcript variant X2
lysosomal acid glucosylceramidase-like, transcript variant X1
lysosomal acid glucosylceramidase-like isoform X2
lysosomal acid glucosylceramidase-like isoform X1
family with sequence similarity 189 member B, transcript variant X2
family with sequence similarity 189 member B, transcript variant X1
secretory carrier-associated membrane protein 3
CDC like kinase 2, transcript variant X2
CDC like kinase 2, transcript variant X1
CDC like kinase 2, transcript variant X3
dual specificity protein kinase CLK2 isoform X2
dual specificity protein kinase CLK2 isoform X1
dual specificity protein kinase CLK2 isoform X3
hyperpolarization activated cyclic nucleotide gated potassium channel 3
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 3
RUN and SH3 domain containing 1, transcript variant X1
RUN and SH3 domain containing 1, transcript variant X2
AP-4 complex accessory subunit RUSC1 isoform X1
AP-4 complex accessory subunit RUSC1 isoform X2
ASH1 like histone lysine methyltransferase, transcript variant X2
ASH1 like histone lysine methyltransferase, transcript variant X1
histone-lysine N-methyltransferase ASH1L isoform X2
histone-lysine N-methyltransferase ASH1L isoform X1
death associated protein 3, transcript variant X2
death associated protein 3, transcript variant X3
death associated protein 3, transcript variant X4
death associated protein 3, transcript variant X1
28S ribosomal protein S29, mitochondrial isoform X1
28S ribosomal protein S29, mitochondrial isoform X2
misato mitochondrial distribution and morphology regulator 1, transcript variant X1
misato mitochondrial distribution and morphology regulator 1, transcript variant X2
GON-4-like protein, transcript variant X4
GON-4-like protein, transcript variant X1
GON-4-like protein, transcript variant X2
GON-4-like protein, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 55 samples with support for all annotated introns
KH domain containing 4, pre-mRNA splicing factor, transcript variant X2
KH domain containing 4, pre-mRNA splicing factor, transcript variant X1
KH homology domain-containing protein 4 isoform X2
KH homology domain-containing protein 4 isoform X1
KH domain containing 4, pre-mRNA splicing factor, transcript variant X3
KH homology domain-containing protein 4 isoform X3
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00423
HORMA domain containing 1, transcript variant X1
HORMA domain containing 1, transcript variant X4
HORMA domain containing 1, transcript variant X2
HORMA domain containing 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
HORMA domain-containing protein 1 isoform X1
HORMA domain-containing protein 1 isoform X3
HORMA domain-containing protein 1 isoform X2
golgi phosphoprotein 3 like, transcript variant X1
golgi phosphoprotein 3 like, transcript variant X2
endosulfine alpha, transcript variant X1
endosulfine alpha, transcript variant X2
MCL1 apoptosis regulator, BCL2 family member
induced myeloid leukemia cell differentiation protein Mcl-1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 86% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA arginine (anticodon UCU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
cell adhesion molecule 3, transcript variant X1
cell adhesion molecule 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 52 samples with support for all annotated introns
cell adhesion molecule 3, transcript variant X2
cell adhesion molecule 3, transcript variant X4
cell adhesion molecule 3, transcript variant X5
atypical chemokine receptor 1 (Duffy blood group)
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 44 samples with support for all annotated introns
dual specificity phosphatase 23, transcript variant X1
dual specificity phosphatase 23, transcript variant X2
dual specificity protein phosphatase 23 isoform X1
dual specificity protein phosphatase 23 isoform X2
cilia- and flagella-associated protein 45-like, transcript variant X1
cilia- and flagella-associated protein 45-like, transcript variant X2
cilia- and flagella-associated protein 45-like, transcript variant X3
cilia- and flagella-associated protein 45-like isoform X1
cilia- and flagella-associated protein 45-like isoform X2
cilia- and flagella-associated protein 45-like isoform X3
cilia- and flagella-associated protein 45-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 72% coverage of the annotated genomic feature by RNAseq alignments
Fc receptor-like protein 3, transcript variant X1
Fc receptor-like protein 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 83% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 84% coverage of the annotated genomic feature by RNAseq alignments
Fc receptor-like protein 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Fc receptor-like protein 2, transcript variant X2
Fc receptor-like protein 2, transcript variant X1
Fc receptor-like protein 2, transcript variant X7
Fc receptor-like protein 2, transcript variant X6
Fc receptor-like protein 2, transcript variant X11
Fc receptor-like protein 2, transcript variant X24
Fc receptor-like protein 2, transcript variant X25
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Fc receptor-like protein 2, transcript variant X22
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Fc receptor-like protein 2, transcript variant X26
Fc receptor-like protein 2, transcript variant X23
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Fc receptor-like protein 2, transcript variant X4
Fc receptor-like protein 1, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Fc receptor-like protein 1, transcript variant X1
Fc receptor-like protein 1, transcript variant X6
Fc receptor-like protein 1, transcript variant X7
Fc receptor-like protein 1, transcript variant X3
Fc receptor-like protein 1, transcript variant X5
Fc receptor-like protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Fc receptor-like protein 1, transcript variant X4
low affinity immunoglobulin gamma Fc region receptor II-like, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
low affinity immunoglobulin gamma Fc region receptor II-like, transcript variant X2
low affinity immunoglobulin gamma Fc region receptor II-like, transcript variant X4
low affinity immunoglobulin gamma Fc region receptor II-like, transcript variant X3
low affinity immunoglobulin gamma Fc region receptor II-like, transcript variant X8
low affinity immunoglobulin gamma Fc region receptor II-like, transcript variant X6
low affinity immunoglobulin gamma Fc region receptor II-like, transcript variant X9
low affinity immunoglobulin gamma Fc region receptor II-like, transcript variant X7
low affinity immunoglobulin gamma Fc region receptor II-like, transcript variant X1
low affinity immunoglobulin gamma Fc region receptor II-like, transcript variant X5
high affinity immunoglobulin gamma Fc receptor I-like isoform X7
high affinity immunoglobulin gamma Fc receptor I-like isoform X2
low affinity immunoglobulin gamma Fc region receptor II-like isoform X3
low affinity immunoglobulin gamma Fc region receptor II-like isoform X8
high affinity immunoglobulin gamma Fc receptor I-like isoform X5
low affinity immunoglobulin gamma Fc region receptor II-like isoform X6
low affinity immunoglobulin gamma Fc region receptor II-like isoform X9
high affinity immunoglobulin gamma Fc receptor I-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
Fc receptor-like protein 2, transcript variant X9
Fc receptor-like protein 2, transcript variant X8
Fc receptor-like protein 2, transcript variant X5
Fc receptor-like protein 2, transcript variant X10
Fc receptor-like protein 2, transcript variant X13
Fc receptor-like protein 2, transcript variant X12
V-set and immunoglobulin domain containing 8, transcript variant X1
V-set and immunoglobulin domain containing 8, transcript variant X3
V-set and immunoglobulin domain containing 8, transcript variant X2
V-set and immunoglobulin domain containing 8, transcript variant X4
V-set and immunoglobulin domain containing 8, transcript variant X5
V-set and immunoglobulin domain-containing protein 8 isoform X1
V-set and immunoglobulin domain-containing protein 8 isoform X3
V-set and immunoglobulin domain-containing protein 8 isoform X2
V-set and immunoglobulin domain-containing protein 8 isoform X4
V-set and immunoglobulin domain-containing protein 8 isoform X5
succinate dehydrogenase complex subunit C, transcript variant X2
succinate dehydrogenase cytochrome b560 subunit, mitochondrial isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
succinate dehydrogenase complex subunit C, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
succinate dehydrogenase cytochrome b560 subunit, mitochondrial isoform X1
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
nuclear receptor subfamily 1 group I member 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
nuclear receptor subfamily 1 group I member 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
nuclear receptor subfamily 1 group I member 3, transcript variant X1
nuclear receptor subfamily 1 group I member 3 isoform X2
nuclear receptor subfamily 1 group I member 3 isoform X3
nuclear receptor subfamily 1 group I member 3 isoform X1
translocase of outer mitochondrial membrane 40 like
LOW QUALITY PROTEIN: mitochondrial import receptor subunit TOM40B
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 43 samples with support for all annotated introns
Fc receptor-like protein 2, transcript variant X18
Fc receptor-like protein 2, transcript variant X16
Fc receptor-like protein 2, transcript variant X15
Fc receptor-like protein 2, transcript variant X14
Fc receptor-like protein 2, transcript variant X17
Fc receptor-like protein 2, transcript variant X21
Fc receptor-like protein 2, transcript variant X20
Fc receptor-like protein 2, transcript variant X19
high affinity immunoglobulin gamma Fc receptor I-like isoform X21
high affinity immunoglobulin gamma Fc receptor I-like isoform X19
Fc receptor-like protein 2, transcript variant X28
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
high affinity immunoglobulin gamma Fc receptor I-like isoform X20
Fc receptor-like protein 2, transcript variant X27
high affinity immunoglobulin gamma Fc receptor I-like isoform X27
low affinity immunoglobulin gamma Fc region receptor II-like isoform X2
low affinity immunoglobulin gamma Fc region receptor III-like
low affinity immunoglobulin gamma Fc region receptor II-like isoform X1
high affinity immunoglobulin epsilon receptor subunit gamma
NADH:ubiquinone oxidoreductase core subunit S2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial
protoporphyrinogen oxidase, transcript variant X2
protoporphyrinogen oxidase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 68% coverage of the annotated genomic feature by RNAseq alignments
ubiquitin carboxyl-terminal hydrolase 21
sodium/potassium-transporting ATPase subunit alpha-2-like
LOW QUALITY PROTEIN: sodium/potassium-transporting ATPase subunit alpha-2-like
lens fiber membrane intrinsic protein-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
Rho GTPase activating protein 30, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Rho GTPase activating protein 30, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Rho GTPase activating protein 30, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
rho GTPase-activating protein 30 isoform X1
rho GTPase-activating protein 30 isoform X3
rho GTPase-activating protein 30 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 97% coverage of the annotated genomic feature by RNAseq alignments, including 67 samples with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: death effector domain-containing protein
aryl hydrocarbon receptor nuclear translocator, transcript variant X11
aryl hydrocarbon receptor nuclear translocator, transcript variant X10
aryl hydrocarbon receptor nuclear translocator, transcript variant X3
aryl hydrocarbon receptor nuclear translocator, transcript variant X9
aryl hydrocarbon receptor nuclear translocator, transcript variant X8
aryl hydrocarbon receptor nuclear translocator, transcript variant X7
aryl hydrocarbon receptor nuclear translocator, transcript variant X6
aryl hydrocarbon receptor nuclear translocator, transcript variant X5
aryl hydrocarbon receptor nuclear translocator, transcript variant X4
aryl hydrocarbon receptor nuclear translocator, transcript variant X2
aryl hydrocarbon receptor nuclear translocator, transcript variant X1
aryl hydrocarbon receptor nuclear translocator isoform X11
aryl hydrocarbon receptor nuclear translocator isoform X10
aryl hydrocarbon receptor nuclear translocator isoform X3
aryl hydrocarbon receptor nuclear translocator isoform X9
aryl hydrocarbon receptor nuclear translocator isoform X8
aryl hydrocarbon receptor nuclear translocator isoform X7
aryl hydrocarbon receptor nuclear translocator isoform X6
aryl hydrocarbon receptor nuclear translocator isoform X5
aryl hydrocarbon receptor nuclear translocator isoform X4
aryl hydrocarbon receptor nuclear translocator isoform X2
aryl hydrocarbon receptor nuclear translocator isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
SET domain bifurcated histone lysine methyltransferase 1, transcript variant X1
SET domain bifurcated histone lysine methyltransferase 1, transcript variant X2
SET domain bifurcated histone lysine methyltransferase 1, transcript variant X3
SET domain bifurcated histone lysine methyltransferase 1, transcript variant X5
histone-lysine N-methyltransferase SETDB1 isoform X1
histone-lysine N-methyltransferase SETDB1 isoform X3
SET domain bifurcated histone lysine methyltransferase 1, transcript variant X4
histone-lysine N-methyltransferase SETDB1 isoform X2
ceramide synthase 2, transcript variant X1
ceramide synthase 2, transcript variant X2
ubiquitin carboxyl-terminal hydrolase MINDY-1
CDC42 small effector 1, transcript variant X2
CDC42 small effector 1, transcript variant X1
nucleoside diphosphate-linked moiety X motif 17
ankyrin repeat domain 35, transcript variant X5
ankyrin repeat domain-containing protein 35 isoform X4
ankyrin repeat domain 35, transcript variant X3
ankyrin repeat domain 35, transcript variant X1
ankyrin repeat domain 35, transcript variant X4
ankyrin repeat domain 35, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
ankyrin repeat domain 35, transcript variant X2
ankyrin repeat domain-containing protein 35 isoform X5
ankyrin repeat domain-containing protein 35 isoform X3
ankyrin repeat domain-containing protein 35 isoform X2
ankyrin repeat domain-containing protein 35 isoform X1
Rho/Rac guanine nucleotide exchange factor 2, transcript variant X2
Rho/Rac guanine nucleotide exchange factor 2, transcript variant X1
Rho/Rac guanine nucleotide exchange factor 2, transcript variant X5
Rho/Rac guanine nucleotide exchange factor 2, transcript variant X6
Rho/Rac guanine nucleotide exchange factor 2, transcript variant X4
Rho/Rac guanine nucleotide exchange factor 2, transcript variant X3
rho guanine nucleotide exchange factor 2 isoform X2
rho guanine nucleotide exchange factor 2 isoform X1
rho guanine nucleotide exchange factor 2 isoform X5
rho guanine nucleotide exchange factor 2 isoform X4
rho guanine nucleotide exchange factor 2 isoform X3
rho guanine nucleotide exchange factor 2 isoform X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
transcription elongation factor SPT6 homolog
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 2 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: DENN domain-containing protein 4B
GATA zinc finger domain containing 2B, transcript variant X2
GATA zinc finger domain containing 2B, transcript variant X3
GATA zinc finger domain containing 2B, transcript variant X1
transcriptional repressor p66-beta isoform X1
transcriptional repressor p66-beta isoform X2
uncharacterized LOC125318406, transcript variant X1
uncharacterized LOC125318406, transcript variant X2
DNA-directed RNA polymerase II subunit RPB1-like, transcript variant X3
DNA-directed RNA polymerase II subunit RPB1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
DNA-directed RNA polymerase II subunit RPB1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 44 samples with support for all annotated introns
DNA-directed RNA polymerase II subunit RPB1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
uncharacterized protein LOC125318403 isoform X2
DNA-directed RNA polymerase II subunit RPB1-like isoform X1
DNA-directed RNA polymerase II subunit RPB1-like isoform X3
DNA-directed RNA polymerase II subunit RPB1-like isoform X4
uncharacterized LOC125318404, transcript variant X1
uncharacterized LOC125318404, transcript variant X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 84% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: solute carrier family 27 member 3
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 67 samples with support for all annotated introns
LOW QUALITY PROTEIN: integrator complex subunit 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 48 samples with support for all annotated introns
transfer RNA methionine (anticodon CAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
mothers against decapentaplegic homolog 4-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
mothers against decapentaplegic homolog 4-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
mothers against decapentaplegic homolog 4-like isoform X2
mothers against decapentaplegic homolog 4-like isoform X1
mothers against decapentaplegic homolog 4-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
mothers against decapentaplegic homolog 4-like isoform X3
chromatin target of PRMT1, transcript variant X4
chromatin target of PRMT1, transcript variant X3
chromatin target of PRMT1 protein isoform X4
chromatin target of PRMT1 protein isoform X3
chromatin target of PRMT1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 67 samples with support for all annotated introns
chromatin target of PRMT1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 67 samples with support for all annotated introns
chromatin target of PRMT1 protein isoform X2
chromatin target of PRMT1 protein isoform X1
S100 calcium binding protein A1, transcript variant X2
S100 calcium binding protein A1, transcript variant X1
S100 calcium binding protein A13, transcript variant X1
S100 calcium binding protein A13, transcript variant X2
S100 calcium binding protein A16, transcript variant X2
S100 calcium binding protein A16, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
protein S100-A9-like, transcript variant X1
protein S100-A9-like, transcript variant X2
protein S100-A8-like, transcript variant X1
protein S100-A8-like, transcript variant X2
keratin-associated protein 5-9-like, transcript variant X1
keratin-associated protein 5-9-like, transcript variant X2
glycine-rich cell wall structural protein-like
claw keratin-like, transcript variant X2
claw keratin-like, transcript variant X1
feather keratin 1-like, transcript variant X3
feather keratin 1-like, transcript variant X1
feather keratin 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins
keratin-associated protein 10-3-like, transcript variant X1
keratin-associated protein 10-3-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 86% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
uncharacterized LOC125318423, transcript variant X1
uncharacterized LOC125318423, transcript variant X2
keratinocyte proline-rich protein-like, transcript variant X4
keratinocyte proline-rich protein-like, transcript variant X3
keratinocyte proline-rich protein-like, transcript variant X2
keratinocyte proline-rich protein-like, transcript variant X1
keratinocyte proline-rich protein-like isoform X2
keratinocyte proline-rich protein-like isoform X4
keratinocyte proline-rich protein-like isoform X3
keratinocyte proline-rich protein-like isoform X1
keratin-associated protein 4-12-like, transcript variant X2
keratin-associated protein 4-12-like, transcript variant X1
keratin-associated protein 4-12-like isoform X2
keratin-associated protein 5-4-like isoform X1
COPI coat complex subunit alpha, transcript variant X1
COPI coat complex subunit alpha, transcript variant X3
COPI coat complex subunit alpha, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
uncharacterized LOC125318185, transcript variant X7
uncharacterized LOC125318185, transcript variant X4
uncharacterized LOC125318185, transcript variant X8
uncharacterized LOC125318185, transcript variant X9
uncharacterized LOC125318185, transcript variant X1
uncharacterized LOC125318185, transcript variant X3
uncharacterized LOC125318185, transcript variant X2
uncharacterized LOC125318185, transcript variant X10
uncharacterized LOC125318185, transcript variant X5
uncharacterized LOC125318185, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized PE-PGRS family protein PE_PGRS20-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 50 samples with support for all annotated introns
LOW QUALITY PROTEIN: vang-like protein 2
uncharacterized LOC125318182, transcript variant X2
uncharacterized LOC125318182, transcript variant X1
uncharacterized LOC125318182, transcript variant X4
uncharacterized LOC125318182, transcript variant X3
uncharacterized protein LOC125318182 isoform X3
uncharacterized protein LOC125318182 isoform X1
uncharacterized protein LOC125318182 isoform X2
T-lymphocyte surface antigen Ly-9-like, transcript variant X3
T-lymphocyte surface antigen Ly-9-like, transcript variant X2
T-lymphocyte surface antigen Ly-9-like, transcript variant X4
T-lymphocyte surface antigen Ly-9-like isoform X4
T-lymphocyte surface antigen Ly-9-like isoform X2
T-lymphocyte surface antigen Ly-9-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
signaling lymphocytic activation molecule family member 1
signaling lymphocytic activation molecule
kirre like nephrin family adhesion molecule 1
SLAM family member 8-like, transcript variant X4
uncharacterized protein LOC125318354 isoform X3
SLAM family member 8-like, transcript variant X1
SLAM family member 8-like, transcript variant X2
SLAM family member 8-like, transcript variant X3
ETS variant transcription factor 3, transcript variant X2
ETS variant transcription factor 3, transcript variant X1
rho guanine nucleotide exchange factor 11-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 60 samples with support for all annotated introns
LOW QUALITY PROTEIN: sodium channel modifier 1
LysM domain containing 1, transcript variant X9
LysM domain containing 1, transcript variant X30
LysM domain containing 1, transcript variant X3
LysM domain containing 1, transcript variant X22
LysM domain containing 1, transcript variant X23
LysM domain containing 1, transcript variant X26
LysM domain containing 1, transcript variant X34
LysM domain containing 1, transcript variant X20
LysM domain containing 1, transcript variant X27
LysM domain containing 1, transcript variant X13
LysM domain containing 1, transcript variant X18
LysM domain containing 1, transcript variant X16
LysM domain containing 1, transcript variant X19
LysM domain containing 1, transcript variant X14
LysM domain containing 1, transcript variant X4
LysM domain containing 1, transcript variant X12
LysM domain containing 1, transcript variant X17
LysM domain containing 1, transcript variant X6
LysM domain containing 1, transcript variant X21
LysM domain containing 1, transcript variant X29
LysM domain containing 1, transcript variant X33
LysM domain containing 1, transcript variant X28
LysM domain containing 1, transcript variant X8
LysM domain containing 1, transcript variant X7
LysM domain containing 1, transcript variant X25
LysM domain containing 1, transcript variant X37
LysM domain containing 1, transcript variant X31
LysM domain containing 1, transcript variant X32
LysM domain containing 1, transcript variant X2
LysM domain containing 1, transcript variant X15
LysM domain containing 1, transcript variant X1
LysM domain containing 1, transcript variant X10
LysM domain containing 1, transcript variant X11
LysM domain containing 1, transcript variant X35
LysM domain containing 1, transcript variant X36
LysM domain containing 1, transcript variant X5
LysM domain containing 1, transcript variant X24
LysM domain containing 1, transcript variant X41
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
LysM domain containing 1, transcript variant X40
LysM domain containing 1, transcript variant X42
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
LysM domain containing 1, transcript variant X50
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
LysM domain containing 1, transcript variant X47
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
LysM domain containing 1, transcript variant X39
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
LysM domain containing 1, transcript variant X44
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
LysM domain containing 1, transcript variant X43
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
LysM domain containing 1, transcript variant X38
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
LysM domain containing 1, transcript variant X49
LysM domain containing 1, transcript variant X48
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
LysM domain containing 1, transcript variant X46
LysM domain containing 1, transcript variant X45
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
lysM and putative peptidoglycan-binding domain-containing protein 1 isoform X9
lysM and putative peptidoglycan-binding domain-containing protein 1 isoform X3
lysM and putative peptidoglycan-binding domain-containing protein 1 isoform X26
lysM and putative peptidoglycan-binding domain-containing protein 1 isoform X20
lysM and putative peptidoglycan-binding domain-containing protein 1 isoform X27
lysM and putative peptidoglycan-binding domain-containing protein 1 isoform X13
lysM and putative peptidoglycan-binding domain-containing protein 1 isoform X18
lysM and putative peptidoglycan-binding domain-containing protein 1 isoform X16
lysM and putative peptidoglycan-binding domain-containing protein 1 isoform X19
lysM and putative peptidoglycan-binding domain-containing protein 1 isoform X14
lysM and putative peptidoglycan-binding domain-containing protein 1 isoform X4
lysM and putative peptidoglycan-binding domain-containing protein 1 isoform X12
lysM and putative peptidoglycan-binding domain-containing protein 1 isoform X17
lysM and putative peptidoglycan-binding domain-containing protein 1 isoform X6
lysM and putative peptidoglycan-binding domain-containing protein 1 isoform X21
lysM and putative peptidoglycan-binding domain-containing protein 1 isoform X33
lysM and putative peptidoglycan-binding domain-containing protein 1 isoform X28
lysM and putative peptidoglycan-binding domain-containing protein 1 isoform X8
lysM and putative peptidoglycan-binding domain-containing protein 1 isoform X7
lysM and putative peptidoglycan-binding domain-containing protein 1 isoform X31
lysM and putative peptidoglycan-binding domain-containing protein 1 isoform X32
lysM and putative peptidoglycan-binding domain-containing protein 1 isoform X2
lysM and putative peptidoglycan-binding domain-containing protein 1 isoform X1
lysM and putative peptidoglycan-binding domain-containing protein 1 isoform X10
lysM and putative peptidoglycan-binding domain-containing protein 1 isoform X11
lysM and putative peptidoglycan-binding domain-containing protein 1 isoform X5
lysM and putative peptidoglycan-binding domain-containing protein 1 isoform X24
lysM and putative peptidoglycan-binding domain-containing protein 1 isoform X30
lysM and putative peptidoglycan-binding domain-containing protein 1 isoform X22
lysM and putative peptidoglycan-binding domain-containing protein 1 isoform X23
lysM and putative peptidoglycan-binding domain-containing protein 1 isoform X34
lysM and putative peptidoglycan-binding domain-containing protein 1 isoform X29
lysM and putative peptidoglycan-binding domain-containing protein 1 isoform X25
lysM and putative peptidoglycan-binding domain-containing protein 1 isoform X37
lysM and putative peptidoglycan-binding domain-containing protein 1 isoform X15
lysM and putative peptidoglycan-binding domain-containing protein 1 isoform X36
lysM and putative peptidoglycan-binding domain-containing protein 1 isoform X35
lysM and putative peptidoglycan-binding domain-containing protein 1 isoform X40
lysM and putative peptidoglycan-binding domain-containing protein 1 isoform X39
lysM and putative peptidoglycan-binding domain-containing protein 1 isoform X38
lysM and putative peptidoglycan-binding domain-containing protein 1 isoform X41
rho guanine nucleotide exchange factor 11-like, transcript variant X2
rho guanine nucleotide exchange factor 11-like, transcript variant X1
rho guanine nucleotide exchange factor 11-like isoform X2
rho guanine nucleotide exchange factor 11-like isoform X1
rho guanine nucleotide exchange factor 11-like, transcript variant X4
rho guanine nucleotide exchange factor 11-like isoform X4
rho guanine nucleotide exchange factor 11-like, transcript variant X3
rho guanine nucleotide exchange factor 11-like isoform X3
leucine-rich repeat extensin-like protein 3
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 2 bases in 2 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: putative PIP5K1A and PSMD4-like protein
zinc finger protein 687, transcript variant X1
zinc finger protein 687, transcript variant X2
zinc finger protein 687, transcript variant X3
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 45 samples with support for all annotated introns
LOW QUALITY PROTEIN: phosphatidylinositol 4-kinase beta
regulatory factor X5, transcript variant X12
regulatory factor X5, transcript variant X1
regulatory factor X5, transcript variant X3
regulatory factor X5, transcript variant X6
regulatory factor X5, transcript variant X8
regulatory factor X5, transcript variant X13
regulatory factor X5, transcript variant X15
regulatory factor X5, transcript variant X14
regulatory factor X5, transcript variant X5
regulatory factor X5, transcript variant X11
regulatory factor X5, transcript variant X4
regulatory factor X5, transcript variant X9
regulatory factor X5, transcript variant X10
regulatory factor X5, transcript variant X7
regulatory factor X5, transcript variant X2
methanethiol oxidase-like, transcript variant X2
LOW QUALITY PROTEIN: methanethiol oxidase-like
methanethiol oxidase-like, transcript variant X1
methanethiol oxidase-like, transcript variant X3
pogo transposable element derived with ZNF domain
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 3 bases in 3 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 3 bases in 3 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: pogo transposable element with ZNF domain
Fc receptor-like protein 4, transcript variant X1
Fc receptor-like protein 4, transcript variant X2
Fc receptor-like protein 4, transcript variant X3
eukaryotic translation initiation factor 3 subunit A-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 94% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
threonyl-tRNA synthetase 2, mitochondrial
regulation of nuclear pre-mRNA domain containing 2, transcript variant X2
regulation of nuclear pre-mRNA domain containing 2, transcript variant X1
regulation of nuclear pre-mRNA domain-containing protein 2 isoform X2
regulation of nuclear pre-mRNA domain-containing protein 2 isoform X1
U4/U6 small nuclear ribonucleoprotein Prp3
mitochondrial ribosomal protein S21, transcript variant X1
mitochondrial ribosomal protein S21, transcript variant X2
mitochondrial ribosomal protein S21, transcript variant X3
28S ribosomal protein S21, mitochondrial
circadian associated repressor of transcription
circadian-associated transcriptional repressor
carbonic anhydrase 14, transcript variant X2
carbonic anhydrase 14, transcript variant X1
aph-1 homolog A, gamma-secretase subunit, transcript variant X1
aph-1 homolog A, gamma-secretase subunit, transcript variant X2
gamma-secretase subunit APH-1A isoform X1
gamma-secretase subunit APH-1A isoform X2
uncharacterized LOC125318344, transcript variant X1
uncharacterized LOC125318344, transcript variant X2
acidic nuclear phosphoprotein 32 family member E
acidic leucine-rich nuclear phosphoprotein 32 family member E
pleckstrin homology domain containing O1
pleckstrin homology domain-containing family O member 1
vacuolar protein sorting-associated protein 45
OTU deubiquitinase 7B, transcript variant X1
OTU deubiquitinase 7B, transcript variant X3
OTU deubiquitinase 7B, transcript variant X2
myotubularin related protein 11, transcript variant X3
myotubularin-related protein 11 isoform X3
myotubularin related protein 11, transcript variant X1
myotubularin related protein 11, transcript variant X4
myotubularin-related protein 11 isoform X1
myotubularin-related protein 11 isoform X4
myotubularin related protein 11, transcript variant X2
myotubularin-related protein 11 isoform X2
bolA family member 1, transcript variant X1
bolA family member 1, transcript variant X2
hemojuvelin BMP co-receptor, transcript variant X3
hemojuvelin BMP co-receptor, transcript variant X1
hemojuvelin BMP co-receptor, transcript variant X2
hemojuvelin BMP co-receptor, transcript variant X4
thioredoxin interacting protein, transcript variant X1
thioredoxin interacting protein, transcript variant X2
thioredoxin-interacting protein isoform X1
thioredoxin-interacting protein isoform X2
RNA polymerase III subunit GL, transcript variant X4
RNA polymerase III subunit GL, transcript variant X3
RNA polymerase III subunit GL, transcript variant X2
RNA polymerase III subunit GL, transcript variant X1
DNA-directed RNA polymerase III subunit RPC7-like isoform X1
DNA-directed RNA polymerase III subunit RPC7-like isoform X2
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 3 bases in 3 codons; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: ankyrin repeat domain-containing protein 34A
ring finger protein 115, transcript variant X5
ring finger protein 115, transcript variant X1
ring finger protein 115, transcript variant X4
ring finger protein 115, transcript variant X3
ring finger protein 115, transcript variant X2
ring finger protein 115, transcript variant X6
E3 ubiquitin-protein ligase RNF115 isoform X6
E3 ubiquitin-protein ligase RNF115 isoform X2
E3 ubiquitin-protein ligase RNF115 isoform X4
E3 ubiquitin-protein ligase RNF115 isoform X3
E3 ubiquitin-protein ligase RNF115 isoform X1
E3 ubiquitin-protein ligase RNF115 isoform X5
RNA polymerase III subunit C, transcript variant X1
RNA polymerase III subunit C, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
RNA polymerase III subunit C, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
DNA-directed RNA polymerase III subunit RPC3 isoform X1
DNA-directed RNA polymerase III subunit RPC3 isoform X2
DNA-directed RNA polymerase III subunit RPC3 isoform X3